Ulf Neumann

Years Active: 2019-2019
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Ulf Neumann, Mike Ufer, Laura H Jacobson, Marie-Laure Rouzade-Dominguez, Gunilla Huledal, Carine Kolly, Rainer M Lüönd, Rainer Machauer, Siem J Veenstra, Konstanze Hurth, Heinrich Rueeger, Marina Tintelnot-Blomley, Matthias Staufenbiel, Derya R Shimshek, Ludovic Perrot, Wilfried Frieauff, Valerie Dubost, Hilmar Schiller, Barbara Vogg, Karen Beltz, Alexandre Avrameas, Sandrine Kretz, Nicole Pezous, Jean-Michel Rondeau, Nicolau Beckmann, Andreas Hartmann, Stefan Vormfelde, Olivier J David, Bruno Galli, Rita Ramos, Ana Graf, Cristina Lopez Lopez
The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease. EMBO molecular medicine 10 (11) (2019)
Ulf Neumann, Rainer Machauer, Derya R Shimshek
The β-secretase (BACE) inhibitor NB-360 in preclinical models: From amyloid-β reduction to downstream disease-relevant effects. British journal of pharmacology 176 (18) (2019)
Finn Peters, Hazal Salihoglu, Katrin Pratsch, Etienne Herzog, Martina Pigoni, Carmelo Sgobio, Stefan F Lichtenthaler, Ulf Neumann, Jochen Herms
Tau deletion reduces plaque-associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease. The EMBO journal 38 (23) (2019)

Ulf Neumann.css-eqlu8i{font-size:small;padding-left:4px;}